v3.26.1
Balance Sheet Items
12 Months Ended
Dec. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Balance Sheet Items

4. BALANCE SHEET ITEMS

 

Prepaid expenses and other current asset consist of the following as of December 31, 2025 and 2024 (in thousands):

 

 

 

2025

 

 

2024

 

Prepaid expenses

 

$

196

 

 

$

642

 

Prepaid research and development costs

 

 

11

 

 

 

29

 

Other current assets

 

 

355

 

 

 

535

 

Total

 

$

562

 

 

$

1,206

 

 

Property and equipment, net, consists of the following as of December 31, 2025 and 2024 (in thousands):

 

 

 

2025

 

 

2024

 

Computer equipment and software

 

$

151

 

 

$

192

 

Furniture and fixtures

 

 

263

 

 

 

328

 

Lab equipment

 

 

1,446

 

 

 

1,485

 

Leasehold improvements

 

 

198

 

 

 

201

 

Property and equipment

 

 

2,058

 

 

 

2,206

 

Less accumulated depreciation

 

 

(1,453

)

 

 

(1,320

)

Property and equipment—net

 

$

605

 

 

$

886

 

 

Depreciation expense for the years ended December 31, 2025 and 2024 was $266 and $389, respectively.

Accrued liabilities as of December 31, 2025 and 2024 consist of the following (in thousands):

 

 

 

2025

 

 

2024

 

Accrued other liabilities

 

$

627

 

 

$

1,335

 

Accrued clinical trial liability

 

 

310

 

 

 

1,391

 

Total

 

$

937

 

 

$

2,726